Document is current

Article History

Received: 12 June 2025

Accepted: 18 August 2025

First Online: 7 December 2025

Declarations

:

: JI reports grants from AstraZeneca, Amgen, National Health and Medical Research Council, and National Breast Cancer Foundation, outside the submitted work. CLC received honorarium and research grants from Amgen Inc to conduct “Bone-Targeted Agents (BTAs) Awareness Campaign for Prostate Cancer Patients with Bone Metastasis” and “Validation of the osteoporosis prediction algorithm for Chinese using logistic regression and advanced machine learning approach.” WCYL received research funding outside the submitted work from AIR@InnoHK administered by Innovation and Technology Commission. ICKW received research grants from Amgen Inc to conduct study on “Global Epidemiology of Hip Fracture” and “Bone-Targeting Agents Among Asian Patients with Bone Metastases from Solid Tumors.” JSB is supported by a National Health and Medical Research Council (NHMRC) Boosting Dementia Research Leadership Fellowship and has received grant funding or consulting funds from the NHMRC, Victorian Government Department of Health and Human Services, Dementia Australia Research Foundation, Yulgilbar Foundation, Aged Care Quality and Safety Commission, Dementia Centre for Research Collaboration, Pharmaceutical Society of Australia, Society of Hospital Pharmacists of Australia, GlaxoSmithKline Supported Studies Programme, Amgen, and several aged care provider organizations unrelated to this work. All grants and consulting funds were paid to the employing institution. SW, GSQT, SJHK, MTYL, CWS, ECCL, MHCH, TTM, and IDC declare that they have no conflict of interest.